These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 15940558

  • 1. High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide.
    Benenson E, Fries JW, Heilig B, Pollok M, Rubbert A.
    Clin Rheumatol; 2005 Jun; 24(3):251-7. PubMed ID: 15940558
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M, Goyal A, Jaryal A, Sharma A, Gupta PK, Ramachandran R, Kumar V, Kohli HS, Sakhuja V, Jha V, Gupta KL.
    Kidney Int; 2016 Jan; 89(1):235-42. PubMed ID: 26489028
    [Abstract] [Full Text] [Related]

  • 4. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puéchal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L, French Vasculitis Study Group.
    N Engl J Med; 2008 Dec 25; 359(26):2790-803. PubMed ID: 19109574
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug 25; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 6. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study.
    Mehra S, Usdadiya JB, Jain VK, Misra DP, Negi VS.
    Rheumatol Int; 2018 Apr 25; 38(4):557-568. PubMed ID: 29450636
    [Abstract] [Full Text] [Related]

  • 7. Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade.
    Kleinert J, Lorenz M, Köstler W, Hörl W, Sunder-Plassmann G, Soleiman A.
    Wien Klin Wochenschr; 2004 May 31; 116(9-10):334-8. PubMed ID: 15237661
    [Abstract] [Full Text] [Related]

  • 8. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V.
    Lupus; 2018 Apr 31; 27(4):647-656. PubMed ID: 29105558
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C, Ligtenberg G, Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Kidney Int; 2006 Aug 31; 70(4):732-42. PubMed ID: 16820790
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C, European Vasculitis Study Group.
    N Engl J Med; 2003 Jul 03; 349(1):36-44. PubMed ID: 12840090
    [Abstract] [Full Text] [Related]

  • 13. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
    Mejía-Vilet JM, Arreola-Guerra JM, Córdova-Sánchez BM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R.
    J Rheumatol; 2015 Nov 03; 42(11):2082-91. PubMed ID: 26373566
    [Abstract] [Full Text] [Related]

  • 14. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
    Ong LM, Hooi LS, Lim TO, Goh BL, Ahmad G, Ghazalli R, Teo SM, Wong HS, Tan SY, Shaariah W, Tan CC, Morad Z.
    Nephrology (Carlton); 2005 Oct 03; 10(5):504-10. PubMed ID: 16221103
    [Abstract] [Full Text] [Related]

  • 15. Maximum tolerable dose of cyclophosphamide and azathioprine in Pakistani patients with primary renal disease.
    Ali SS, Rabbani MA, Moinuddin SS, Virani S, Farooque F, Salam A, Ahmad A.
    J Pak Med Assoc; 2004 Jan 03; 54(1):39-42. PubMed ID: 15058645
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis.
    Lamprecht P, Voswinkel J, Lilienthal T, Nolle B, Heller M, Gross WL, Gause A.
    Rheumatology (Oxford); 2002 Nov 03; 41(11):1303-7. PubMed ID: 12422004
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis.
    Langford CA, Talar-Williams C, Sneller MC.
    Arthritis Rheum; 2004 Apr 15; 51(2):278-83. PubMed ID: 15077273
    [Abstract] [Full Text] [Related]

  • 19. Cyclophosphamide-intolerant Wegener's granulomatosis successfully treated with mycophenolate mofetil.
    Osuna A, Garrido J.
    Acta Reumatol Port; 2008 Apr 15; 33(2):224-8. PubMed ID: 18604190
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.